96 related articles for article (PubMed ID: 27237819)
1. The Role of Cancer Biomarkers in HIV Infected Hosts.
Galati D; Zanotta S
Curr Med Chem; 2016; 23(22):2333-49. PubMed ID: 27237819
[TBL] [Abstract][Full Text] [Related]
2. Cancer in the HIV-Infected Host: Epidemiology and Pathogenesis in the Antiretroviral Era.
Brickman C; Palefsky JM
Curr HIV/AIDS Rep; 2015 Dec; 12(4):388-96. PubMed ID: 26475669
[TBL] [Abstract][Full Text] [Related]
3. The Spectrum of Malignancies among Adult HIV Cohort in Poland between 1995 and 2012: A Retrospective Analysis of 288 Cases.
Kowalski J; Cholewińska G; Pyziak-Kowalska K; Jabłonowska E; Barałkiewicz G; Grzeszczuk A; Leszczyszyn-Pynka M; Olczak A; Jankowska M; Mikuła T; Bociąga-Jasik M; Firląg-Burkacka E; Horban A
Contemp Oncol (Pozn); 2015; 19(3):226-35. PubMed ID: 26557764
[TBL] [Abstract][Full Text] [Related]
4. Overview of cancer incidence and mortality among people living with HIV/AIDS in British Columbia, Canada: Implications for HAART use and NADM development.
Chiu CG; Smith D; Salters KA; Zhang W; Kanters S; Milan D; Montaner JSG; Coldman A; Hogg RS; Wiseman SM
BMC Cancer; 2017 Apr; 17(1):270. PubMed ID: 28410587
[TBL] [Abstract][Full Text] [Related]
5. HIV infection and cancer in the era of highly active antiretroviral therapy (Review).
Barbaro G; Barbarini G
Oncol Rep; 2007 May; 17(5):1121-6. PubMed ID: 17390054
[TBL] [Abstract][Full Text] [Related]
6. Use of statins and risk of AIDS-defining and non-AIDS-defining malignancies among HIV-1 infected patients on antiretroviral therapy.
Galli L; Spagnuolo V; Poli A; Salpietro S; Gianotti N; Cossarini F; Carbone A; Nozza S; Bossolasco S; Bigoloni A; Lazzarin A; Castagna A
AIDS; 2014 Oct; 28(16):2407-15. PubMed ID: 25160933
[TBL] [Abstract][Full Text] [Related]
7. Do antiretrovirals reduce the risk of non-AIDS-defining malignancies?
Silverberg MJ; Abrams DI
Curr Opin HIV AIDS; 2009 Jan; 4(1):42-51. PubMed ID: 19339938
[TBL] [Abstract][Full Text] [Related]
8. T CD4+ cells count among patients co-infected with human immunodeficiency virus type 1 (HIV-1) and human T-cell leukemia virus type 1 (HTLV-1): high prevalence of tropical spastic paraparesis/HTLV-1-associated myelopathy (TSP/HAM).
Casseb J; Posada-Vergara MP; Montanheiro P; Fukumori LM; Olah I; Smid J; Duarte AJ; Penalva de Oliveira AC
Rev Inst Med Trop Sao Paulo; 2007; 49(4):231-3. PubMed ID: 17823752
[TBL] [Abstract][Full Text] [Related]
9. Trends in AIDS-defining and non-AIDS-defining malignancies among HIV-infected patients: 1989-2002.
Bedimo R; Chen RY; Accortt NA; Raper JL; Linn C; Allison JJ; Dubay J; Saag MS; Hoesley CJ
Clin Infect Dis; 2004 Nov; 39(9):1380-4. PubMed ID: 15494916
[TBL] [Abstract][Full Text] [Related]
10. Epidemiologic trends of cancer diagnoses among HIV-infected children in Spain from 1997 to 2008.
Alvaro-Meca A; Micheloud D; Jensen J; Díaz A; García-Alvarez M; Resino S
Pediatr Infect Dis J; 2011 Sep; 30(9):764-8. PubMed ID: 21494172
[TBL] [Abstract][Full Text] [Related]
11. Low CD4/CD8 Ratio Is Associated with Non AIDS-Defining Cancers in Patients on Antiretroviral Therapy: ANRS CO8 (Aproco/Copilote) Prospective Cohort Study.
Hema MN; Ferry T; Dupon M; Cuzin L; Verdon R; Thiébaut R; Protopopescu C; Leport C; Raffi F; Le Moing V;
PLoS One; 2016; 11(8):e0161594. PubMed ID: 27548257
[TBL] [Abstract][Full Text] [Related]
12. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy.
Clifford GM; Polesel J; Rickenbach M; Dal Maso L; Keiser O; Kofler A; Rapiti E; Levi F; Jundt G; Fisch T; Bordoni A; De Weck D; Franceschi S;
J Natl Cancer Inst; 2005 Mar; 97(6):425-32. PubMed ID: 15770006
[TBL] [Abstract][Full Text] [Related]
13. Risk of cancers during interrupted antiretroviral therapy in the SMART study.
Silverberg MJ; Neuhaus J; Bower M; Gey D; Hatzakis A; Henry K; Hidalgo J; Lourtau L; Neaton JD; Tambussi G; Abrams DI
AIDS; 2007 Sep; 21(14):1957-63. PubMed ID: 17721103
[TBL] [Abstract][Full Text] [Related]
14. HIV-Associated Cancer Biomarkers: A Requirement for Early Diagnosis.
Dlamini Z; Mbele M; Makhafola TJ; Hull R; Marima R
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360891
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive evaluation of the immune risk phenotype in successfully treated HIV-infected individuals.
Ndumbi P; Gilbert L; Tsoukas CM
PLoS One; 2015; 10(2):e0117039. PubMed ID: 25647167
[TBL] [Abstract][Full Text] [Related]
16. Reduced hepatitis B virus (HBV)-specific CD4+ T-cell responses in human immunodeficiency virus type 1-HBV-coinfected individuals receiving HBV-active antiretroviral therapy.
Chang JJ; Wightman F; Bartholomeusz A; Ayres A; Kent SJ; Sasadeusz J; Lewin SR
J Virol; 2005 Mar; 79(5):3038-51. PubMed ID: 15709024
[TBL] [Abstract][Full Text] [Related]
17. Lower CD4+ T lymphocyte nadirs may indicate limited immune reconstitution in HIV-1 infected individuals on potent antiretroviral therapy: analysis of immunophenotypic marker results of AACTG 5067.
D'Amico R; Yang Y; Mildvan D; Evans SR; Schnizlein-Bick CT; Hafner R; Webb N; Basar M; Zackin R; Jacobson MA
J Clin Immunol; 2005 Mar; 25(2):106-15. PubMed ID: 15821887
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
[TBL] [Abstract][Full Text] [Related]
19. Cancer risk in people infected with human immunodeficiency virus in the United States.
Engels EA; Biggar RJ; Hall HI; Cross H; Crutchfield A; Finch JL; Grigg R; Hylton T; Pawlish KS; McNeel TS; Goedert JJ
Int J Cancer; 2008 Jul; 123(1):187-94. PubMed ID: 18435450
[TBL] [Abstract][Full Text] [Related]
20. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
